The feeling of visiting the pharmaceutical factory
Release time:
2020-09-11
Pharmaceutical Factory Visit Feelings
7# On March 10 , the pharmaceutical company held a thematic training on "How to Write Press Release " and led the correspondent to visit the pharmaceutical factory. 2 years later, I returned to this "familiar battlefield " , thinking of the work scene of the workshop site QA and the craftsman in those days: watching the key positions to see the personnel operation process, following the workshop master to learn the post operation skills, and shuttling between the workshop and the central control laboratory to deliver samples every day, review batch production record ... The sense of urgency that counts against the clock, the frustration of lack of expertise and skills, always forces yourself to seek progress. In the pharmaceutical factory after the integration of
, the QAteam is reorganized. Although the personnel are young, they have ideas and are steadfast and willing to work. The safety and environmental protection management of the factory has been strengthened. Checkpoints and entrance guards have been set up at the entrance of the explosion-proof area. Non-factory personnel are not allowed to enter the factory without safety training, safety equipment and authorization from the factory leaders. The whole process of numerical control is implemented for sewage treatment and discharge, waste gas collection and spray incineration, rainwater discharge and other links, which is convenient for data traceability, and remote monitoring of the operation process is enabled. Managers can also check and supervision in real time; the factory has implemented internal control standardization, added some visual image publicity elements, and pasted positive energy slogans on the walls of the workshop office corridor to enhance the cohesion and centripetal force of the production team. Boldly set up a youth management team in the workshop, increase the training of youth teams in key positions in the workshop, and use the model of "old with new, strong with weak " , arrange a group of young people with ideas, innovation, and solid professional knowledge and skills to reasonable positions. These are all the changes in the pharmaceutical factory that I have seen and learned during this visit. Watching these changes also made me feel a lot.
Quality is the life of an enterprise. As a quality management personnel, I think whether it is a production enterprise or an operating enterprise, it can form an internal quality management system of the enterprise according to the 5key elements of personnel, equipment, materials, documents and environment, and carry out compliant production and business activities according to the system requirements and internal control standards. The production department strictly adheres to the quality control, makes efforts on these key elements, and supervises the implementation department in detail to ensure the quality compliance of the products. In the retail link of the business department, we have the most contact with patients. Now the complaints of patients have shifted from the price to the quality of the products. In addition to the appearance, the quality complaints are the use effect of drugs. In addition to the daily quality checks of drug administration and medical insurance, retail chain departments will encounter "alternative supervision " of "unannounced visits and anti-counterfeiting " personnel from time to time. If the inspection results of the latter are exposed to the media or the Internet, it will be for a retail pharmacy or even the entire operating enterprise, there will be threats ranging from small to large numbers of loyal buyers to "shutdown " . Therefore, we must always stay awake, do not step on the red line, do not touch the bottom line, avoid behavioral activities that can cause hidden dangers, and ensure the healthy and sustainable development of enterprises.
In strict quality at the same time, but also further innovation. In the development process of Jianfeng Group, we saw the boldness and courage of "dare to be the first and dare to be the first " from Du Zihong, the former head of Jianfeng Group. He led Jianfeng people to turn a small cement factory into the first listed company in China's cement industry. Since the current chairman Jiang Xiaomeng took office, the group has always adjusted the company's industrial structure, established the market with quality and brand, and strived to be the "leader " in the professional field, centering on the strategic idea of "cooperation and innovation to strengthen the main business, standardizing science and seeking development " . Over the years, Jianfeng Pharmaceutical has implemented the intellectual property policy of "intellectual property rights help enterprise development, scientific and technological innovation creates a century-old peak " , and actively cooperated with China University of Science and Technology, Zhejiang University of Technology, Sichuan Institute of Antibiotic Industry and other units to jointly build a scientific research innovation platform integrating "production, learning and research " , according to the development direction and market positioning of the group company, we have actively carried out scientific research and achieved fruitful results.
In addition to technological innovation, we also need innovation in management mode. First of all, managers should "down-to-earth " , often go to the grass-roots level, listen more to public opinion, solve people's worries, and tap skilled talents. Set an example, learn more and ask more, listen more and do more, master new ideas and skills in a timely manner, and solve problems in key steps in a timely manner. Secondly, enterprises should strengthen the training of talents in professional fields, carry out more lectures and training in professional fields, and expand the talent team. At the same time, enterprises should also carry forward the positive patriotic spirit internally, infiltrate the positive energy into the managers of each class and the employees of each department in a horizontal and vertical way, so as to enhance the employees' sense of belonging, mission and responsibility. (Lang Minxiao)
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31